Patten Group, Inc. Bristol Myers Squibb CO Transaction History

Patten Group, Inc.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $10,726 - $12,504	-200 Reduced 5.77%	3,267 $204,000
Q2 2021 Aug 03, 2021	SELL	$61.91 - $67.42 $928 - $1,011	-15 Reduced 0.43%	3,467 $232,000
Q2 2020 Jul 20, 2020	BUY	$54.82 - $64.09 $190,883 - $223,161	3,482 New	3,482 $205,000
Q1 2020 Apr 16, 2020	SELL	$46.4 - $67.43 $160,868 - $233,779	-3,467 Closed	0 $0
Q4 2019 Jan 14, 2020	BUY	$49.21 - $64.19 $170,611 - $222,546	3,467 New	3,467 $223,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $242,483 - $314,442	-4,973 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $331 - $373	6 Added 0.12%	4,973 $309,000
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $22,384 - $27,900	-443 Reduced 8.19%	4,967 $275,000
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $7,669 - $8,829	-128 Reduced 2.31%	5,410 $342,000
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $5,694 - $6,208	-95 Reduced 1.69%	5,538 $339,000
Q3 2017 Dec 13, 2017	BUY	$55.23 - $63.74 $5,743 - $6,628	104 Added 1.88%	5,633 $359,000
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $220 - $254	-4 Reduced 0.07%	5,529 $359,000
Q2 2017 Aug 14, 2017	BUY	N/A	5,533	5,533 $310,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Patten Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Patten Group, Inc. with notifications on news.